Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Veterans Exploring Treatment Solutions and Coalition for Psychedelic Safety and Education Join Forces to Support Senate Bill 1012 for Regulating Access to Psychedelics


News provided by

Veterans Exploring Treatment Solutions (VETS)

Apr 15, 2024, 09:00 ET

Share this article

Share toX

Share this article

Share toX

VETS announces co-sponsorship of Senate Bill (SB) 1012 for regulated access and education of psychedelics in California

CORONADO, Calif., April 15, 2024 /PRNewswire-PRWeb/ -- Veterans Exploring Treatment Solutions (VETS), a leading non-profit organization dedicated to ending veteran suicide, has joined forces with the Coalition For Psychedelic Safety and Education (CPSE) in support of California Senate Bill (SB) 1012 which enables regulated access to facilitated use of certain psychedelics and creates a public-private fund to develop a first-in-the-nation education campaign to increase public understanding of potential risks, benefits, and safer-use practices of psychedelics.

SB 1012, introduced by Senator Scott Wiener with Assembly Members Marie Waldron and Josh Lowenthal, aims to establish a professional licensing board and comprehensive program under the California Business, Consumer Services, and Housing Agency to enable access for adults 21 and older to certain psychedelic substances under the supervision of a licensed and trained facilitator at approved locations. An Expert Oversight Committee will be appointed by the Governor that will develop, with the licensing board, rigorous training programs, ethical standards, scope of practice guidelines, and regulatory oversight of the substances, locations, and facilitators. The bill also establishes a public-private fund to support public health education and enhance awareness about the safe use of psychedelics, potential risks, and where to seek assistance in case of adverse effects.

Established in 2019, VETS has been instrumental in aiding nearly 1,000 U.S. Special Forces veterans and their spouses through a comprehensive program encompassing grants for psychedelic-assisted therapy (P-AT) treatment abroad, preparation and integration coaching, and ongoing community support. VETS' innovative approach significantly enhances the well-being of its grantees by employing diverse therapeutic modalities, notably P-AT, administered by trained medical experts. These professionals adhere to rigorous safeguards and uphold the highest ethical standards, ensuring a secure and holistic treatment experience for all recipients of VETS' support.

"VETS uniquely understands the suffering that exists within the veteran community, as well as the potential for psychedelic therapies to effectively combat these complex challenges. By creating a regulatory framework for psychedelic-assisted therapies, with an emphasis on facilitated support, safeguards, education, harm reduction mechanisms, and controls, more individuals who are suffering will have access to these potentially life-saving treatments," said Amber Capone, CEO and Co-Founder of VETS. "By co-sponsoring SB 1012, VETS is committed to assisting in the development of the promising frameworks that could impact not only the people of California but have the potential to be replicated in other states across the nation - thereby increasing access to patients and their families."

"The loss of my child to a distressing journey with psilocybin has been a driving force behind my effort to increase awareness of the risks of these powerful substances. The prevailing narrative about psychedelics that I was seeing both before and after my child died highlighted the potential benefits without mentioning the risks. The public needs to understand the potential harms and how to stay as safe as possible when using these substances. SB 1012 represents a critical step towards ensuring safer access while acknowledging and mitigating the associated risks," said Susan Sagy, Executive Director of the Coalition for Psychedelic Safety and Education.

"With its emphasis on public health education and professional oversight, SB 1012 paves the way for informed and responsible psychedelic use in California. Without safety nets and robust education to inform of risks, the unregulated use of psychedelics is rising in the state and causing an increase in hospitalizations due to adverse effects. Our coalition, along with VETS, stands to prevent more people from experiencing loss as a result of unsafe practices and to provide an alternative for those seeking support," said Beth Parker, Coalition for Psychedelic Safety and Education.

"After losing my husband Chad, a Navy SEAL, to suicide in 2018, I've dedicated my life to advocating for military and veteran communities dealing with the invisible wounds that so many carry. Psychedelic-assisted therapies have played a pivotal role in my own journey through unimaginable grief and could hold tremendous promise in addressing the issues facing those who've served. We must let science, safety, and education serve as guideposts in this critical fight to save lives, understanding that regulated access is paramount in achieving safe and sustainable outcomes," said Sara Wilkinson, veteran mental health advocate and member of VETS' Board of Directors.

About VETS

Founded in 2019, Veterans Exploring Treatment Solutions (VETS) is a 501(c)(3) non-profit organization working to end the veteran suicide epidemic by providing resources, research, and advocacy for U.S. military veterans seeking psychedelic-assisted therapies for traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), addiction, and other health conditions. VETS envisions a world where our veterans have access to the most advanced healthcare options to heal from the mental and physical wounds of war.

About CPSE

The Coalition for Psychedelic Safety and Education (CPSE) is a group of mental health and research experts, lawyers, public health professionals, ethicists, youth advocates, and families who have lost family members to psychedelic use. We know and appreciate the potential healing benefits of psychedelics. We want to see an end to drug war policies. We simply believe that education about risks and harms and safeguards like regulated access must be part of a responsible approach to psychedelic policy reform.

Media Contact

Brad Burge, Veterans Exploring Treatment Solutions (VETS), 1 (650)-863-6887, [email protected], vetsolutions.org

SOURCE Veterans Exploring Treatment Solutions (VETS)

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.